| 生长激素在IVF-ET周期子宫内膜发育不良患者中的应用 |
| |
| 引用本文： | 罗国群,邓伟芬,马文敏.生长激素在IVF-ET周期子宫内膜发育不良患者中的应用[J].生殖与避孕,2011,31(11):769-772,739. |
| |
| 作者姓名： | 罗国群 邓伟芬 马文敏 |
| |
| 作者单位： | 佛山市妇幼保健院生殖中心,佛山,528000 |
| |
| 摘 要： | 目的:探讨生长激素(growth hormone,GH)在体外受精-胚胎移植(in vitro fertilization-em-bryo transfer,IVF-ET)治疗中对子宫内膜发育不良者子宫内膜及临床结局的影响。方法:IVF-ET患者共67例,均由于子宫内膜发育不良而致IVF-ET种植失败,再次行IVF-ET治疗时随机分为研究组(加用GH治疗,32例)和对照组(未使用GH治疗,35例),统计分析患者的临床结局。结果:患者Gn用量、平均获卵数、受精率、优质胚胎率组间无统计学差异(P>0.05);研究组子宫内膜厚度、形态及子宫内膜和内膜下血流均较对照组有明显改善(P<0.01);研究组的胚胎种植率(31.4%)及临床妊娠率(39.5%)明显高于对照组(15.7%和19.8%)(P<0.01),早期流产率明显减低(14.6%vs 21.4%)(P<0.01)。结论:对内膜发育不良的患者进行IVF-ET治疗时加用GH可能是通过改善子宫内膜对胚胎的容受性,从而提高胚胎种植率及临床妊娠率,降低早期流产率。
|
| 关 键 词： | 生长激素(GH) 体外受精-胚胎移植(IVF-ET) 子宫内膜 临床结局 |
Growth Hormone (GH) Co-treatment for Patients with the Maldevelopment of Endometrium Undergoing IVF-ET |
| |
| Guo-qun LUO,Wei-feng DENG,Wen-min MA.Growth Hormone (GH) Co-treatment for Patients with the Maldevelopment of Endometrium Undergoing IVF-ET[J].Reproduction and Contraception,2011,31(11):769-772,739. |
| |
| Authors: | Guo-qun LUO Wei-feng DENG Wen-min MA |
| |
| Institution: | Guo-qun LUO,Wei-feng DENG,Wen-min MA(Reproductive Medicine Center of Foshan Maternal and Children's Hospital,Foshan,528000) |
| |
| Abstract: | Objective: To evaluate the efficacy of growth hormone(GH) co-treatment for patients with the maldevelopment of endometrium undergoing in vitro fertilization-embryo transfer(IVF-ET).Methods: The clinical data of 67 patients who were failed in previous IVF-ET treatment as a result of maldevelopment of endometrium were analyzed.In the second cycle,the 67 patients were randomly divided into two groups,the study group consisting of 32 cases with using GH and the control group consisting of 35 cases without using... |
| |
| Keywords: | growth hormone(GH) in vitro fertilization-embryo transfer(IVF-ET) endometrium clinical outcome |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
